While IKBKB rs13278372 and serum IKBKB protein levels showed no significant association with AMD development, the existence of the A allele of IKBKB rs13278372 was related to a worse response to anti-VEGF treatment, indicating its potential as a marker for treatment outcomes. This evidence concerns the gene VEGFA and age-related macular degeneration.